Universe Pharmaceuticals Inc
1 hedge funds and large institutions have $151K invested in Universe Pharmaceuticals Inc in 2021 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 3 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
55% less capital invested
Capital invested by funds: $332K → $151K (-$181K)
67% less funds holding
Funds holding: 3 → 1 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$138K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$128K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$125K |
| 3 |
Jane Street
New York
|
-$61K |
UPC Hedge Fund Activity: Q2 2021 in Review
1 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Universe Pharmaceuticals Inc (UPC) for Q2 2021, worth a combined $151K — down 55% from $332K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of UPC and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was Bank of Montreal, opening a new position worth an estimated $138K. The largest seller was Millennium Management, exiting entirely with an estimated $128K sold.
- 1 institutional investor held Universe Pharmaceuticals Inc (UPC) as of Q2 2021, down from 3 in Q1 2021.
- Funds reported $151K of Universe Pharmaceuticals Inc stock for Q2 2021, down 55% quarter-over-quarter.
- 1 fund opened new Universe Pharmaceuticals Inc positions in Q2 2021 and 3 closed out, a net change of -2 holders.
- The largest Universe Pharmaceuticals Inc buyer in Q2 2021 was Bank of Montreal, an estimated $138K added.
- The largest Universe Pharmaceuticals Inc seller in Q2 2021 was Millennium Management, an estimated $128K sold.
Based on aggregated 13F filings for Q2 2021.